175 related articles for article (PubMed ID: 36926452)
1. Synthesis and Preclinical Evaluation of a Novel Fluorine-18-Labeled Tracer for Positron Emission Tomography Imaging of Bruton's Tyrosine Kinase.
Li K; Wang M; Akoglu M; Pollard AC; Klecker JB; Alfonso P; Corrionero A; Prendiville N; Qu W; Parker MFL; Turkman N; Cohen JA; Tonge PJ
ACS Pharmacol Transl Sci; 2023 Mar; 6(3):410-421. PubMed ID: 36926452
[TBL] [Abstract][Full Text] [Related]
2. [
Skaddan MB; Wooten DW; Wilcox KC; Voorbach MJ; Reuter DR; Jia ZJ; Foster-Duke KD; Hickson JA; Vaidyanathan S; Reed AD; Tovcimak AE; Guo Q; Comley RA; Lee L; Finnema SJ; Mudd SR
Mol Imaging Biol; 2022 Oct; 24(5):830-841. PubMed ID: 35482146
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
Kwan KH; Burvenich IJG; Centenera MM; Goh YW; Rigopoulos A; Dehairs J; Swinnen JV; Raj GV; Hoy AJ; Butler LM; Scott AM; White JM; Ackermann U
Nucl Med Biol; 2021 Feb; 93():37-45. PubMed ID: 33310350
[TBL] [Abstract][Full Text] [Related]
4. One-step
Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
7. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
[TBL] [Abstract][Full Text] [Related]
8. Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis.
Nuesslein-Hildesheim B; Ferrero E; Schmid C; Huck C; Smith P; Tisserand S; Rubert J; Bornancin F; Eichlisberger D; Cenni B
J Neuroinflammation; 2023 Aug; 20(1):194. PubMed ID: 37633912
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
10. Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.
Rozkiewicz D; Hermanowicz JM; Kwiatkowska I; Krupa A; Pawlak D
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903645
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.
Mendes-Bastos P; Brasileiro A; Kolkhir P; Frischbutter S; Scheffel J; Moñino-Romero S; Maurer M
Allergy; 2022 Aug; 77(8):2355-2366. PubMed ID: 35175630
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and biological evaluation of
Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
[TBL] [Abstract][Full Text] [Related]
13. Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.
Angst D; Gessier F; Janser P; Vulpetti A; Wälchli R; Beerli C; Littlewood-Evans A; Dawson J; Nuesslein-Hildesheim B; Wieczorek G; Gutmann S; Scheufler C; Hinniger A; Zimmerlin A; Funhoff EG; Pulz R; Cenni B
J Med Chem; 2020 May; 63(10):5102-5118. PubMed ID: 32083858
[TBL] [Abstract][Full Text] [Related]
14. Radiosynthesis of a Bruton's tyrosine kinase inhibitor, [
Dahl K; Turner T; Vasdev N
J Labelled Comp Radiopharm; 2020 Sep; 63(11):482-487. PubMed ID: 32726870
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
16. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
[TBL] [Abstract][Full Text] [Related]
17. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
18. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of an
Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
[TBL] [Abstract][Full Text] [Related]
20. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
